Sign in
4

Changes in Ownership

ARS Pharmaceuticals, Inc. Filed Acc 0001475990-26-000009

Options or other derivatives

  • Chief Legal Officer acquired 1,199,482 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Slebir John L Chief Legal Officer 2026-11-02 Grant or award · Stock Option (right to buy) +1,199,482 1,199,482 D
Loading xslF345X06/form4-11042026_091100.xml…